Latest Metformin Stories
Fad diets come and go, but might there be something to the ones that involve consuming grapefruit and grapefruit juice? New UC Berkeley research suggests that a closer look at grapefruit juice is warranted.
-- Reducing Incidence of Limiting Side Effects Could Increase the Utility of this Effective, Safe and Affordable Therapy -- BROOMFIELD, Colo., Sept.
Results from Phase 2b Clinical Study in Patients with Type 2 Diabetes Provide Evidence that SGLT1 inhibition with LX4211 Provides a Clinically Meaningful Benefit THE WOODLANDS, Texas,
A recently-published literature review reveals that people with prediabetes have a 15 percent higher risk of developing cancer — and the level of risk differs depending on the type of cancer.
No overall statistically significant increased risk of bladder cancer in patients ever exposed to pioglitazone in a completed 10-year epidemiological study OSAKA, Japan, Aug.
A large-scale study from Cardiff University reveals that people with Type 2 diabetes can live longer than those without the condition, thanks to a widely prescribed blood glucose control medication.
In Phase 3 studies, INVOKANA® plus metformin lowered blood sugar and reduced secondary endpoints of body weight and systolic blood pressure to a greater degree than metformin alone RARITAN,
Metformin and SGLT2 inhibitors together reduce the blood sugar levels considerably more effectively than either drug alone.
- Combination of linagliptin and metformin significantly reduced blood glucose levels compared with linagliptin alone RIDGEFIELD, Conn. and INDIANAPOLIS, Aug.
LONDON, July 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: